Dermatitis

NEW ORLEANS — Patients with atopic dermatitis experienced a rapid and sustained reduction in itch with topical roflumilast cream treatment, according to phase 3 study results presented at the American Academy of Dermatology Annual Meeting.

NEW ORLEANS — Although Black patients with atopic dermatitis treated with dupilumab experienced fewer adverse events than their white counterparts, the difference did not reach statistical significance, according to a poster presented here.

Results showed that Vtama cream 1% was safe, effective and well tolerated in a phase 3 study evaluating the cream in adults and children aged as young as 2 years with atopic dermatitis, Dermavant Sciences announced in a press release.

An immune and lipid profile on the surface of infants’ skin may predict the future development of atopic dermatitis months before the condition’s chronic onset, according to a study.

The measurement of immunoglobulin E levels in children hospitalized for atopic dermatitis exacerbation or infectious complications may assist in diagnosis differentiation, according to a study.

Roflumilast cream 0.15% and 0.05% demonstrated consistent efficacy across endpoints and a favorable tolerability and safety profile in the treatment of adults and adolescents with mild to moderate atopic dermatitis, according to a study.

SAN ANTONIO — Living further from major roadways correlated with reduced risk for atopic dermatitis, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Black children with atopic dermatitis appeared less likely than white children to undergo an evaluation by an allergist, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

A new drug application submitted to the FDA seeks approval of roflumilast foam 0.3% for adults and adolescents with moderate to severe seborrheic dermatitis, Arcutis Biotherapeutics announced in a press release.

MIAMI BEACH, Fla. — Decreasing the concern about food-induced atopic dermatitis will allow patients to focus on proper skin therapy and lower the risk of developing food allergies, according to a speaker at South Beach Symposium.